ITH5 -Emilia Romagna
Innovation Performance Group (2021) : Strong
Total population (2019): 4,459,477
Population per km² (2019): 202
Proportion population older 65 year %: 23,95%
The region has a focus on the emerging fields of regenerative and restorative medicine, as well as pharmaceutical and omics sciences and inclusive services and usable technologies for healthy living and active aging.
Emilia-Romagna is involved in a number of major initiatives in the field of personalised medicine including Hologene, Custom Implants, Italian Infrastructure for Regenerative Medicine, SUPER HPC and Big Data and Italian Biobanks network.
Is the region looking for international/European/interregional collaboration opportunities? Yes - Identification of standard protocols to collect data and support on how to overcome the barriers about privacy regulation.
National level: SNSI - National smart specialization
National level: ALISEI applied life science national cluster strategic plan
Regional Strategy for Research and Innovation for Smart Specialisation (RIS3)
Policy document PM@RIS3: Yes
Hologene 7 2.0
SUPER HPC and Big Data
BBMRI.it Italian Biobanks network
Collaboration with Piedmont Region
BIOGEN - Genetic Biobank
Biorepository of tissue and blood samples, lymphocytes and DNA from patients affected by solitary/multiple osteochondroma and peripheral chondrosarcoma
LTTA Biobank (Laboratory for Advanced Therapy Technologies)
Digital Innovation Hubs:
SMILE-DIH (Smart Manufacturing Innovation for Lean Excellence center - Digital Innovation Hub)
Is the region represented in: Horizon2020; Regional Smart Specialisation Strategy Platforms/Partnerships (RIS3); EIT Health/InnoStars/Regional Innovation Scheme (RIS); other?
BBMRI EUS3 Platform - Personalized Medicine
H2020 - SMEINST - Oncosmart - ONCOlogic patient profiling and personalized treatment through SMART bedside diagnostics
H2020- SMEINST- BIOFOSTE - Clinical validation of a BIOmarker panel For OSTEoarthritis diagnosis: BIOFOSTE
H2020 - SC1- ADIPOA2 - Clinical trial of autologous adipose-derived mesenchymal stromal cells (ASC) in the treatment of mild to moderate osteoarthritis
1M+Genome initiative - country level member
European Regions Research & Innovation Network (ERRIN)
Image attribution - By TUBS - Own workThis SVG map includes elements that have been taken or adapted from this map: Italy location map.svg (by NordNordWest)., CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=14512796